Skip to content

Salivary Inflammatory Biomarkers: Predictors & Comparative Effects of Sonicare/Elite-Flexcare in Stages of Perio Disease

Studies of Salivary Inflammatory Biomarkers During Biofilm Overgrowth: Confirmation of Predictors and Comparative Effects of Sonicare/Elite-Flexcare in Various Stages of Periodontal Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02187185
Enrollment
175
Registered
2014-07-10
Start date
2009-04-30
Completion date
2012-03-31
Last updated
2018-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation, Periodontitis

Keywords

Inflammatory biomarkers, Periodontitis

Brief summary

This research study has 2 aims. One aim is to see if saliva testing can show if a person has healthy gum tissue, gingivitis, or one of three degrees of periodontitis - mild, moderate, or severe. The second aim is to examine the effect of the Sonicare Elite/Flexcare toothbrush on periodontitis.

Detailed description

Randomized controlled trial to determine clinical and inflammatory benefits of Sonicare Flexcare tooth brushing following experimental induction of biofilm overgrowth in various periodontal conditions. This research study has both a Diagnostic Aim and a Treatment Aim. Aim #1 is to examine the utility of candidate inflammatory biomarkers within saliva to discriminate between health, gingivitis, mild, moderate and severe periodontis; and to discriminate between active versus inactive states of periodontal disease to see if these basal levels can predict the clinical response to biofilm overgrowth among various periodontal conditions; Aim #2 is to extend the claim of the anti-inflammatory and anti-infective efficacy of the Sonicare/Elite-Flexcare as compared to manual brushing to include 4 levels of periodontal disease \[BGI-G, P1, P2 and P3\]. The devices used in this study are subject only to Class I (general controls) and considered exempt from the premarket notification procedures and not subject to section 510(k), 515, or 520(m,) of the FDC Act in order to be legally marketed. Thus, the study does not meet the definition of an Applicable Clinical Trial.

Interventions

OTHERSonicare/Elite-Flexcare Toothbrush

Philips Oral Healthcare product - battery powered menchanic toothbrush with nylon bristles

OTHERManual Toothbrush

traditional (non-mechanical) toothbrush with nylon bristles and plastic handle

Sponsors

Philips Oral Healthcare
CollaboratorINDUSTRY
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

1. adult males or females between the ages of 18 and 75 years (inclusive). 2. able and willing to follow study procedures and instructions. 3. read, understood and signed an informed consent form. 4. present with at least 8 teeth in the functional dentition with a minimum of 3 adjacent teeth with interproximal papilla in each posterior sextant that will have the stent. 5. be in good general health. 6. present with one of the following five categories to be considered for enrollment * BGI health (all PD\<3mm, BOP\<10%) * BGI-gingivitis (all PD≤3mm, BOP≥10%) * BGI-P1 (1+ site with PD\>3mm, BOP≤10%) * BGI-P2 (1+ site with PD\>3mm, BOP\>10% but BOP≤50%) * BGI-P3 (1+ site with PD\>3mm, BOP\>50%)

Exclusion criteria

1. chronic disease with oral manifestations or active infectious diseases such as hepatitis, HIV or tuberculosis. 2. gross oral pathology. 3. treatment with antibiotics for any medical or dental condition within 1 month prior to the screening examination. 4. chronic treatment (i.e., two weeks or more) with any medication known to affect periodontal status (e.g., phenytoin, calcium antagonists, cyclosporin, anticoagulants, non-steroidal anti-inflammatory drugs, high dose aspirin such as \>100mg per day) within one month of the screening examination. 5. ongoing medications initiated less than three months prior to enrollment (i.e., medications for chronic medical conditions must be initiated at least three months prior to enrollment). 6. clinically significant organ disease including impaired renal function, and/or any bleeding disorder. 7. severe unrestored caries, or any condition that is likely to require antibiotic treatment during the study, including the need for prophylactic antibiotic. 8. use any tobacco products or who have used tobacco products within the previous six months of the screening examination. 9. pregnant, or expect to become pregnant within the next three months and individuals nursing. 10. dental appliances that will interfere with stent construction.

Design outcomes

Primary

MeasureTime frame
Change from baseline in (inflammatory biomarkers?) among a range of periodontal disease groups after using Sonicare Elite/Flexcare versus manual toothbrush for four weeks.Four weeks

Secondary

MeasureTime frame
Identification of salivary biomarkers that can distinguish between and among the 5 disease categories (health, gingivitis, and 3 levels of periodontal disease).4 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026